open access

Vol 82, No 6 (2011)
ARTICLES
Get Citation

Epidemiological models for breast cancer risk estimation

Lech Rogulski, Przemysław Oszukowski
Ginekol Pol 2011;82(6).

open access

Vol 82, No 6 (2011)
ARTICLES

Abstract

Abstract Breast cancer is the most common malignancy affecting women worldwide. Effective prevention and screening are only possible if there is precise risk prediction for cancer in an individual patient. Mathematical models for estimation of breast cancer risk were developed on the basis of epidemiological studies. It is possible to identify women at high risk for this disease using patient history data and the analysis of various demographic and hereditary factors. The Gail risk model, originally developed in the United States to selectively identify patients for breast cancer chemoprevention studies, remains to be the most widely used and properly validated. The Cuzick-Tyrer model is more advanced and was developed for the International Breast Intervention Study (IBIS-1). It incorporates the assessment of additional hereditary factors, body mass index, menopausal status and hormone replacement therapy use. Genetic models aiming at calculating individual risk for BRCA1 and BRCA2 mutation carrier-state have also been designed. In this review we discuss the usefulness of various risk estimation models and their possible application for breast cancer prophylaxis.

Abstract

Abstract Breast cancer is the most common malignancy affecting women worldwide. Effective prevention and screening are only possible if there is precise risk prediction for cancer in an individual patient. Mathematical models for estimation of breast cancer risk were developed on the basis of epidemiological studies. It is possible to identify women at high risk for this disease using patient history data and the analysis of various demographic and hereditary factors. The Gail risk model, originally developed in the United States to selectively identify patients for breast cancer chemoprevention studies, remains to be the most widely used and properly validated. The Cuzick-Tyrer model is more advanced and was developed for the International Breast Intervention Study (IBIS-1). It incorporates the assessment of additional hereditary factors, body mass index, menopausal status and hormone replacement therapy use. Genetic models aiming at calculating individual risk for BRCA1 and BRCA2 mutation carrier-state have also been designed. In this review we discuss the usefulness of various risk estimation models and their possible application for breast cancer prophylaxis.
Get Citation

Keywords

breast cancer, risk assessment, Statistical models, chemoprevention

About this article
Title

Epidemiological models for breast cancer risk estimation

Journal

Ginekologia Polska

Issue

Vol 82, No 6 (2011)

Bibliographic record

Ginekol Pol 2011;82(6).

Keywords

breast cancer
risk assessment
Statistical models
chemoprevention

Authors

Lech Rogulski
Przemysław Oszukowski

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl